XML 37 R23.htm IDEA: XBRL DOCUMENT v3.21.1
Summary of Significant Accounting Policies Summary of Significant Accounting Principles (Tables)
 9 Months Ended
Mar. 31, 2021
Accounting Policies [Abstract]  
Interest and Other Income
The following table summarizes the components of other income (expense), net:
 Three Months Ended March 31, Nine Months Ended March 31,
2021202020212020
Gains (losses) on derivatives not designated as hedging instruments (1) $18,724 $18,039 $(13,791)$25,730 
Currency-related (losses) gains, net (2)(8,841)3,950 (2,957)3,183 
Other (losses) gains(98)548 581 258 
Total other income (expense), net$9,785 $22,537 $(16,167)$29,171 
_____________________
(1) Primarily relates to both realized and unrealized gains and losses on derivative currency forward and option contracts and interest rate swaps not designated as hedging instruments, including gains of $6,394 and $6,759 for the three and nine months ended March 31, 2021, respectively, related to certain interest rate swap contracts that have been de-designated from hedge accounting due to their ineffectiveness, which had an immaterial impact in the comparative periods..
(2) We have significant non-functional currency intercompany financing relationships that we may change at times and are subject to currency exchange rate volatility. The currency-related (losses) gains, net are primarily driven by this intercompany activity for the periods presented. In addition, we have certain cross-currency swaps designated as cash flow hedges which hedge the remeasurement of certain intercompany loans; both are presented in the same component above. The unrealized gains related to cross-currency swaps for the three months ended March 31, 2021 were $6,288, and the unrealized losses were $5,233 for the nine months ended March 31, 2021, as compared to unrealized gains of $1,807 and $3,627 for the three and nine months ended March 31, 2020, respectively.
Schedule of Weighted Average Number of Shares
The following table sets forth the reconciliation of the weighted-average number of ordinary shares:
 Three Months Ended March 31, Nine Months Ended March 31,
 2021202020212020
Weighted average shares outstanding, basic26,003,675 26,024,229 25,984,300 27,608,387 
Weighted average shares issuable upon exercise/vesting of outstanding share options/RSUs/warrants— — — 709,053 
Shares used in computing diluted net (loss) income per share attributable to Cimpress plc26,003,675 26,024,229 25,984,300 28,317,440 
Weighted average anti-dilutive shares excluded from diluted net (loss) income per share attributable to Cimpress plc (1) (2)621,172 464,638 485,067 — 
_____________________
(1) On May 1, 2020, we entered into a financing arrangement with Apollo Global Management, Inc., which included 7-year warrants with a strike price of $60 that have a potentially dilutive impact on our weighted average shares outstanding. For the three and nine months ended March 31, 2021, the weighted average anti-dilutive effect of the warrants was 412,473 and 348,973 shares, respectively. Refer to Note 9 for additional details about the arrangement.
(2) In the periods in which a net loss is recognized, the impact of share options, RSUs, RSAs and warrants is not included as they are anti-dilutive.